Double Standards in Medical Research in Developing Countries
BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7475.1190 (Published 11 November 2004) Cite this as: BMJ 2004;329:1190- Udo Schuklenk, professor of bioethics and human rights (schuklenku@medicine.wits.ac.za)
- University of the Witwatersrand, Johannesburg, South Africa
Ruth Macklin, a senior bioethicist with a longstanding interest in research ethics, has produced a very readable overview and analysis of the main issues in one of the most acrimonious international debates the field of ethics has seen in recent times. Unlike the excited bickering about stem cell research and reproductive cloning, this debate affects the lives of real people and is quite unlike those interminable debates about the moral standing of accumulations of a few hundred cells that some people still misleadingly call “persons.”
At the heart of the debate lies this question: what standards of care are ethically required when commercial …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.